- Home
- XERS vs NBN Comparison
XERS vs NBN Comparison
Compare XERS & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- NBN
- Stock Information
- Founded
- XERS 2005
- NBN 1872
- Country
- XERS United States
- NBN United States
- Employees
- XERS 394
- NBN N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- NBN Major Banks
- Sector
- XERS Health Care
- NBN Finance
- Exchange
- XERS Nasdaq
- NBN Nasdaq
- Market Cap
- XERS 1.3B
- NBN 853.5M
- IPO Year
- XERS 2018
- NBN N/A
- Fundamental
- Price
- XERS $7.93
- NBN $110.24
- Analyst Decision
- XERS Strong Buy
- NBN Buy
- Analyst Count
- XERS 7
- NBN 2
- Target Price
- XERS $8.00
- NBN $97.50
- AVG Volume (30 Days)
- XERS 3.5M
- NBN 98.6K
- Earning Date
- XERS 08-07-2025
- NBN 07-28-2025
- Dividend Yield
- XERS N/A
- NBN 0.04%
- EPS Growth
- XERS N/A
- NBN 32.98
- EPS
- XERS N/A
- NBN 10.08
- Revenue
- XERS $246,025,000.00
- NBN $204,086,000.00
- Revenue This Year
- XERS $43.89
- NBN $17.75
- Revenue Next Year
- XERS $20.40
- NBN $9.91
- P/E Ratio
- XERS N/A
- NBN $10.95
- Revenue Growth
- XERS 35.62
- NBN 33.67
- 52 Week Low
- XERS $2.48
- NBN $65.55
- 52 Week High
- XERS $8.02
- NBN $110.84
- Technical
- Relative Strength Index (RSI)
- XERS 80.36
- NBN 69.68
- Support Level
- XERS $7.27
- NBN $100.82
- Resistance Level
- XERS $8.02
- NBN $111.10
- Average True Range (ATR)
- XERS 0.32
- NBN 2.77
- MACD
- XERS 0.03
- NBN 0.82
- Stochastic Oscillator
- XERS 93.99
- NBN 92.72
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About NBN Northeast Bank
Northeast Bank provides banking and financial services to individual and corporate customers in the US. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived primarily from interest and dividends from the bank.